How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Septic Arthritis and Osteomyelitis in Finger Caused by Mycoplasma phocimorsus from Brown Bear, Alaska, USA – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Disseminated Histoplasmosis in Persons Living with HIV, France and Overseas Territories,1992–2021 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Community Outbreak of OXA-48–Producing Escherichia coli Linked to Food Premises, New Zealand, 2018–2022 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Emergence and Prevalence of Vibrio cholerae O1 Sequence Type 75 Clonal Complex, Fujian Province, China, 2009–2023 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Multisystemic Disease and Septicemia Caused by Presumptive Burkholderia pseudomallei in American Quarter Horse, Florida, USA – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Scotochromogenic [sko′′to-kro′mo-jǝn-ik] – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Emergence of Distinct Salmonella enterica Serovar Enteritidis Lineage since 2020, South Korea – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Epidemiologic and Genomic Investigation of Sexually Transmitted Shigella sonnei, England – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Early Release – Assessing Readiness of International Investigations into Alleged Biological Weapons Use – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal

Communicable disease threats report, 7-13 June 2025, week 24

Schedule an Appointment

Quick Links

Patient Forms

Contact Us